[Lupus myelitis: value of magnetic resonance and treatment with bolus of methylprednisolone and intravenous cyclophosphamide].
Hernández Hernández
J A
JA
del Blanco Barnusell
J
J
Salvador
J
J
Cuenca
R
R
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007275:Injections, Intravenous; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000008:administration & dosage*; D009187:Myelitis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone
Mielitis lúpica: valor de la resonancia magnética y tratamiento con bolos de metilprednisolona y ciclofosfamida intravenosa.